CollaGenex Periostat Lawsuit Hinges On FDA “Antibiotic” Determination
Executive Summary
A federal judge must determine whether CollaGenex' Periostat is properly classified as an "antibiotic" after preliminarily enjoining FDA from approving generic versions of doxycycline hyclate 20 mg